Canlyniadau Chwilio - Anita K. Wagner
- Dangos 1 - 9 canlyniadau o 9
-
1
30 years of media coverage on high drug prices in the US - a never-ending story or a time for change? gan Christine Leopold, James D Chambers, Anita K Wagner
Cyhoeddwyd 2015Rhif Galw: Llwytho...Connect to this object online.
Wedi'i leoli: Llwytho...
Llyfr -
2
Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand gan Christine Leopold, Christine Y. Lu, Anita K. Wagner
Cyhoeddwyd 2020Rhif Galw: Llwytho...Connect to this object online.
Wedi'i leoli: Llwytho...
Llyfr -
3
Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway gan Mahnum Shahzad, Huseyin Naci, Katharine M. Esselen, Joseph A. Dottino, Anita K. Wagner
Cyhoeddwyd 2024Rhif Galw: Llwytho...Connect to this object online.
Wedi'i leoli: Llwytho...
Llyfr -
4
1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities gan Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner, Dennis Ross-Degnan
Cyhoeddwyd 2020Rhif Galw: Llwytho...Connect to this object online.
Wedi'i leoli: Llwytho...
Llyfr -
5
The Brazilian private pharmaceutical market after the first ten years of the generics law gan Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens, Dennis Ross-Degnan
Cyhoeddwyd 2019Rhif Galw: Llwytho...Connect to this object online.
Wedi'i leoli: Llwytho...
Llyfr -
6
Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020Research in context gan Yuxuan Wei, Yichen Zhang, Ziyue Xu, Guoan Wang, Yue Zhou, Huangqianyu Li, Luwen Shi, Huseyin Naci, Anita K. Wagner, Xiaodong Guan
Cyhoeddwyd 2024Rhif Galw: Llwytho...Connect to this object online.
Wedi'i leoli: Llwytho...
Llyfr -
7
Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context gan Adriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-, Sabine Vogler, Elias Mossialos, Carla L. Tavares-, Huseyin Naci
Cyhoeddwyd 2023Rhif Galw: Llwytho...Connect to this object online.
Wedi'i leoli: Llwytho...
Llyfr -
8
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries gan Christine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, Silvia Valkova, Kees de Joncheere, Hubert GM Leufkens, Anita K Wagner, Dennis Ross-Degnan, Richard Laing
Cyhoeddwyd 2014Rhif Galw: Llwytho...Connect to this object online.
Wedi'i leoli: Llwytho...
Llyfr -
9
Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China gan Dr. Yu Fang, PhD, Anita K Wagner, DrPH, Shimin Yang, BS, Minghuan Jiang, MS, Fang Zhang, PhD, Dennis Ross-Degnan, ScD
Cyhoeddwyd 2013Rhif Galw: Llwytho...Connect to this object online.
Wedi'i leoli: Llwytho...
Llyfr